Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,773.20
(
0.00%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
93.56
(
-1.53%
)
Bitcoin
78,044.35
(
2.25%
)
News Focus
News Focus
Post# of 257433
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: GrthzGd post# 189153

Wednesday, 03/25/2015 3:57:50 PM

Wednesday, March 25, 2015 3:57:50 PM

Post# of 257433

Who would benefit from the trial of a drug seen as likely to fail in P3, and why would a pharma pay for such a trial?

Company management benefits greatly—compared to the alternative of acknowledging failure and shutting down operations; this is what Zebra’s Law is all about (#msg-111988739).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today